Two Sigma Advisers’s Immune Design Corp. IMDZ Stock Holding History

Two Sigma Advisers’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-294,400	Closed	-$1.72M	–	2547
2019 Q1	$1.72M	Buy	294,400 +14,000	+5%	+$47.7K	﹤0.01%	1283
2018 Q4	$365K	Buy	280,400 +121,000	+76%	+$210K	﹤0.01%	1897
2018 Q3	$550K	Sell	159,400 -6,000	-4%	-$22.5K	﹤0.01%	1763
2018 Q2	$753K	Sell	165,400 -3,200	-2%	-$12.7K	﹤0.01%	1740
2018 Q1	$556K	Buy	168,600 +53,600	+47%	+$190K	﹤0.01%	1772
2017 Q4	$449K	Buy	+115,000	New	+$626K	﹤0.01%	1805

Two Sigma Advisers's IMDZ Position: Q2 2019 in Review

Two Sigma Advisers sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 294,400 shares — an estimated $1.72M sold.

Two Sigma Advisers first reported a position in IMDZ in Q4 2017 and held it in 6 quarters. The position peaked at $1.72M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Two Sigma Advisers reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Two Sigma Advisers sold 294,400 Immune Design Corp. shares in Q2 2019, an estimated $1.72M.
Two Sigma Advisers first reported a position in Immune Design Corp. in Q4 2017 and held it in 6 quarters.
Two Sigma Advisers's Immune Design Corp. position peaked at $1.72M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Two Sigma Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.